Synergistic inhibition of angiogenesis by artesunate and captopril in vitro and in vivo

Evidence-based Complementary and Alternative Medicine

Volumn 2013, Issue , 2013, Pages

  Krusche, Benjamin ^a   Arend, Joachim ^a   Efferth, Thomas ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ARTESUNATE; CAPTOPRIL;

ANIMAL CELL; ANTIANGIOGENIC ACTIVITY; ARTICLE; CELL ASSAY; CELL GROWTH; CELL MIGRATION; CHORIOALLANTOIS; CONTROLLED STUDY; COTURNIX COTURNIX; DRUG CYTOTOXICITY; DRUG MECHANISM; DRUG POTENTIATION; EMBRYO; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE STUDY; UMBILICAL VEIN ENDOTHELIAL CELL; VASCULARIZATION;

EID: 84886678708     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2013/454783     Document Type: Article

References (62)

1. Rosslenbroich B., Understanding the organism as a central problem medicine. Forsch Komplementarmed Klass Naturheilkd 2001 8 3 125 136 (Pubitemid 32678930)
2. Leis A. M., Weeks L. C., Verhoef M. J., Principles to guide integrative oncology and the development of an evidence base. Current Oncology 2008 15 supplement 2 s83 s87
3. Post-White J., Hawks R., O'Mara A., Ott M. J., Future directions of CAM research in pediatric oncology. Journal of Pediatric Oncology Nursing 2006 23 5 265 268 2-s2.0-33747082186 10.1177/1043454206291361 (Pubitemid 44215078)
4. Elkins G., Fisher W., Johnson A., Mind-body therapies in integrative oncology. Current Treatment Options in Oncology 2010 11 3-4 128 140 2-s2.0-79951951970 10.1007/s11864-010-0129-x
5. Burns D. S., Theoretical rationale for music selection in oncology intervention research: an integrative review. Journal of Music Therapy 2012 49 7 22
6. Running A., Seright T., Integrative oncology: managing cancer pain with complementary and alternative therapies. Current Pain and Headache Reports 2012 16 4 325 331 10.1007/s11916-012-0275-x
7. Files J. A., Stan D. L., Allen S. V., Pruthi S., Chemoprevention of breast cancer. Womens Health 2012 8 635 646
8. Madka V., Rao C. V., Anti-inflammatory phytochemicals for chemoprevention of colon cancer. Current Cancer Drug Targets 2013 13 5 542 557
9. Lee J. H., Khor T. O., Shu L., Su Z. Y., Fuentes F., Kong A. N., Dietary phytochemicals and cancer prevention: Nrf2 signaling, epigenetics, and cell death mechanisms in blocking cancer initiation and progression. Pharmacology & Therapeutics 2013 137 153 171 10.1016/j.pharmthera.2012.09.008
10. Efferth T., Li P. C. H., Konkimalla V. S. B., Kaina B., From traditional Chinese medicine to rational cancer therapy. Trends in Molecular Medicine 2007 13 8 353 361 2-s2.0-34547179813 10.1016/j.molmed.2007.07.001 (Pubitemid 47126989)
11. Efferth T., Fu Y. J., Zu Y. G., Schwarz G., Konkimalla V. S. B., Wink M., Molecular target-guided tumour therapy with natural products derived from Traditional Chinese Medicine. Current Medicinal Chemistry 2007 14 19 2024 2032 2-s2.0-34548634137 10.2174/092986707781368441 (Pubitemid 47578160)
12. Efferth T., Personalized cancer medicine: from molecular diagnostics to targeted therapy with natural products. Planta Medica 2010 76 11 1143 1154 2-s2.0-77955063009 10.1055/s-0030-1249937
13. Efferth T., Stem cells, cancer stem-like cells, and natural products. Planta Medica 2012 78 935 942 10.1055/s-0031-1298540
14. Ko J. K., Auyeung K. K., Target-oriented mechanisms of novel herbal therapeutics in the chemotherapy of gastrointestinal cancer and inflammation. Current Pharmaceutical Design 2013 19 48 66
15. Klayman D. L., Qinghaosu (Artemisinin): an antimalarial drug from China. Science 1985 228 4703 1049 1055 2-s2.0-0021948029 (Pubitemid 15227365)
16. Hsu E., The history of qing hao {A figure is presented} in the Chinese materia medica. Transactions of the Royal Society of Tropical Medicine and Hygiene 2006 100 6 505 508 2-s2.0-33645877368 10.1016/j.trstmh.2005.09.020
17. You-You T., Mu-Yun N., Yu-Rong Z., Studies on the constituents of Artemisia annua. Part II. Planta Medica 1982 44 3 143 145 2-s2.0-0020063952 (Pubitemid 12101116)
18. Woerdenbag H. J., Moskal T. A., Pras N., Malingré T. M., El-Feraly F. S., Kampinga H. H., Konings A. W. T., Cytotoxicity of artemisinin-related endoperoxides to Ehrlich ascites tumor cells. Journal of Natural Products 1993 56 6 849 856 2-s2.0-0027267309 (Pubitemid 23195612)
19. Moore J. C., Lai H., Li J. R., Ren R. L., McDougall J. A., Singh N. P., Chou C. K., Oral administration of dihydroartemisinin and ferrous sulfate retarded implanted fibrosarcoma growth in the rat. Cancer Letters 1995 98 1 83 87 2-s2.0-0028865074 10.1016/0304-3835(95)03999-D
20. Efferth T., Rücker G., Falkenberg M., Manns D., Olbrich A., Fabry U., Osieka R., Detection of apoptosis in KG-1a leukemic cells treated with investigational drugs. Drug Research 1996 46 2 196 200 2-s2.0-0029986996 (Pubitemid 26079152)
21. Dell'Eva R., Pfeffer U., Vené R., Anfosso L., Forlani A., Albini A., Efferth T., Inhibition of angiogenesis in vivo and growth of Kaposi's sarcoma xenograft tumors by the anti-malarial artesunate. Biochemical Pharmacology 2004 68 12 2359 2366 2-s2.0-8844258698 10.1016/j.bcp.2004.08.021 (Pubitemid 39535108)
22. Li L. N., Zhang H. D., Yuan S. J., Tian Z. Y., Wang L., Sun Z. X., Artesunate attenuates the growth of human colorectal carcinoma and inhibits hyperactive Wnt/ β -catenin pathway. International Journal of Cancer 2007 121 6 1360 1365 2-s2.0-34548088377 10.1002/ijc.22804 (Pubitemid 47293806)
23. Du J. H., Zhang H. D., Ma Z. J., Ji K. M., Artesunate induces oncosis-like cell death in vitro and has antitumor activity against pancreatic cancer xenografts in vivo. Cancer Chemotherapy and Pharmacology 2010 65 5 895 902 2-s2.0-77649189381 10.1007/s00280-009-1095-5
24. Berger T. G., Dieckmann D., Efferth T., Schultz E. S., Funk J. O., Baur A., Schuler G., Artesunate in the treatment of metastatic uveal melanoma-first experiences. Oncology Reports 2005 14 6 1599 1603 2-s2.0-33644672627
25. Jansen F. H., Adoubi I., Comoe J.C K., de Cnodder T., Jansen N., Tschulakow A., Efferth T., First study of oral artenimol-R in advanced cervical cancer: clinical benefit, tolerability and tumor markers. Anticancer Research 2011 31 12 4417 4422 2-s2.0-84855171058
26. Efferth T., Dunstan H., Sauerbrey A., Miyachi H., Chitambar C. R., The anti-malarial artesunate is also active against cancer. International journal of oncology 2001 18 4 767 773 2-s2.0-0035315838
27. Chen H. H., Zhou H. J., Fang X., Inhibition of human cancer cell line growth and human umbilical vein endothelial cell angiogenesis by artemisinin derivatives in vitro. Pharmacological Research 2003 48 3 231 236 2-s2.0-0038689359 10.1016/S1043-6618(03)00107-5 (Pubitemid 36818928)
28. Anfosso L., Efferth T., Albini A., Pfeffer U., Microarray expression profiles of angiogenesis-related genes predict tumor cell response to artemisinins. Pharmacogenomics Journal 2006 6 4 269 278 2-s2.0-33746531759 10.1038/sj.tpj.6500371 (Pubitemid 44137954)
29. Hou J., Wang D., Zhang R., Wang H., Experimental therapy of hepatoma with artemisinin and Its derivatives: in vitro and in vivo activity, chemosensitization, and mechanisms of action. Clinical Cancer Research 2008 14 17 5519 5530 2-s2.0-53049086416 10.1158/1078-0432.CCR-08-0197
30. Li P. C. H., Lam E., Roos W. P., Zdzienicka M. Z., Kaina B., Efferth T., Artesunate derived from traditional Chinese medicine induces DNA damage and repair. Cancer Research 2008 68 11 4347 4351 2-s2.0-49249122781 10.1158/0008-5472.CAN-07-2970
31. Steinbrück L., Pereira G., Efferth T., Effects of artesunate on cytokinesis and G2/M cell cycle progression of tumour cells and budding yeast. Cancer Genomics and Proteomics 2010 7 6 337 346 2-s2.0-78650944133
32. Berdelle N., Nikolova T., Quiros S., Efferth T., Kaina B., Artesunate induces oxidative DNA damage, sustained DNA double-strand breaks, and the ATM/ATR damage response in cancer cells. Molecular Cancer Therapeutics 2011 10 12 2224 2233 2-s2.0-83355166871 10.1158/1535-7163.MCT-11-0534
33. Prisant L. M., Management of hypertension in patients with cardiac disease: use of renin-angiotensin blocking agents. American Journal of Medicine 2008 121 8 S8 S15 2-s2.0-47049114771 10.1016/j.amjmed.2008.05.017 (Pubitemid 351970086)
34. DiBianco R., Adverse reactions with angiotensin converting enzyme (ACE) inhibitors. Medical Toxicology and Adverse Drug Experience 1986 1 2 122 141 2-s2.0-0022472964
35. Volpert O. V., Ward W. F., Lingen M. W., Chesler L., Solt D. B., Johnson M. D., Molteni A., Polverini P. J., Bouck N. P., Captopril inhibits angiogenesis and slows the growth of experimental tumors in rats. Journal of Clinical Investigation 1996 98 3 671 679 2-s2.0-0029916051 (Pubitemid 26349171)
36. Vogt B., Frey F. J., Inhibition of angiogenesis in Kaposi's sarcoma by captopril. Lancet 1997 349 9059 1148 2-s2.0-0342618314 10.1016/S0140-6736(05) 63025-5 (Pubitemid 27168557)
37. Carmeliet P., Jain R. K., Angiogenesis in cancer and other diseases. Nature 2000 407 6801 249 257 2-s2.0-0034648765 10.1038/35025220
38. Giuliano S., Pages G., Mechanisms of resistance to anti-angiogenesis therapies. Biochimie 2013 95 6 1110 1119 10.1016/j.biochi.2013.03.002
39. Wahl O., Oswald M., Tretzel L., Herres E., Arend J., Efferth T., Inhibition of tumor angiogenesis by antibodies, synthetic small molecules and natural products. Current Medicinal Chemistry 2011 18 21 3136 3155 2-s2.0-79959958353 10.2174/092986711796391570
40. Rijken P. F. J. W., Bernsen H. J. J. A., Van Der Kogel A. J., Application of an image analysis system to the quantitation of tumor perfusion and vascularity in human glioma xenografts. Microvascular Research 1995 50 2 141 153 2-s2.0-0029150035 10.1006/mvre.1995.1048
41. Chen H. H., Zhou H. J., Wang W. Q., Wu G. D., Antimalarial dihydroartemisinin also inhibits angiogenesis. Cancer Chemotherapy and Pharmacology 2004 53 5 423 432 2-s2.0-2142650659 10.1007/s00280-003-0751-4 (Pubitemid 38553665)
42. Meshnick S. R., Artemisinin: mechanisms of action, resistance and toxicity. International Journal for Parasitology 2002 32 13 1655 1660 2-s2.0-0037021405 10.1016/S0020-7519(02)00194-7 (Pubitemid 35339455)
43. Eckstein-Ludwig U., Webb R. J., Van Goethem I. D. A., East J. M., Lee A. G., Kimura M., O'Neill P. M., Bray P. G., Ward S. A., Krishna S., Artemisinins target the SERCA of Plasmodium falciparum. Nature 2003 424 6951 957 961 2-s2.0-0042860063 10.1038/nature01813 (Pubitemid 37051688)
44. Jones P. H., Christodoulos K., Dobbs N., Thavasu P., Balkwill F., Blann A. D., Caine G. J., Kumar S., Kakkar A. J., Gompertz N., Talbot D. C., Ganesan T. S., Harris A. L., Combination antiangiogenesis therapy with marimastat, captopril and fragmin in patients with advanced cancer. British Journal of Cancer 2004 91 1 30 36 2-s2.0-3342931576 10.1038/sj.bjc.6601897 (Pubitemid 39013041)
45. Hii S. I., Nicol D. L., Gotley D. C., Thompson L. C., Green M. K., Jonsson J. R., Captopril inhibits tumour growth in a xenograft model of human renal cell carcinoma. British Journal of Cancer 1998 77 6 880 883 2-s2.0-0031937612 (Pubitemid 28101773)
46. Al-Shabanah O., Mansour M., El-Kashef H., Al-Bekairi A., Captopril ameliorates myocardial and hematological toxicities induced by adriamycin. Biochemistry and Molecular Biology International 1998 45 2 419 427 2-s2.0-0031874485 (Pubitemid 28331955)
47. Müller I., Niethammer D., Bruchelt G., Anthracycline-derived chemotherapeutics in apoptosis and free radical cytotoxicity (Review). International Journal of Molecular Medicine 1998 1 2 491 494 2-s2.0-0031987938
48. Efferth T., Kaina B., Toxicity of the antimalarial artemisinin and its dervatives. Critical Reviews in Toxicology 2010 40 5 405 421 2-s2.0-77951436519 10.3109/10408441003610571
49. Christian J. B., Lapane K. L., Hume A. L., Eaton C. B., Weinstock M. A., Association of ACE inhibitors and angiotensin receptor blockers with keratinocyte cancer prevention in the randomized VATTC trial. Journal of the National Cancer Institute 2008 100 17 1223 1232 2-s2.0-51749120817 10.1093/jnci/djn262
50. Yasumatsu R., Nakashima T., Masuda M., Ito A., Kuratomi Y., Nakagawa T., Komune S., Effects of the angiotensin-I converting enzyme inhibitor perindopril on tumor growth and angiogenesis in head and neck squamous cell carcinoma cells. Journal of Cancer Research and Clinical Oncology 2004 130 10 567 573 2-s2.0-5644304562 10.1007/s00432-004-0582-7 (Pubitemid 39371327)
51. Fendrich V., Chen N. M., Neef M., Waldmann J., Buchholz M., Feldmann G., Slater E. P., Maitra A., Bartsch D. K., The angiotensin-I-converting enzyme inhibitor enalapril and aspirin delay progression of pancreatic intraepithelial neoplasia and cancer formation in a genetically engineered mouse model of pancreatic cancer. Gut 2010 59 5 630 637 2-s2.0-77951744260 10.1136/gut.2009. 188961
52. Amaral S. L., Papanek P. E., Greene A. S., Angiotensin II and VEGF are involved in angiogenesis induced by short-term exercise training. American Journal of Physiology-Heart and Circulatory Physiology 2001 281 3 H1163 H1169 2-s2.0-0034829216
53. Attoub S., Gaben A. M., Al-Salam S., Al Sultan M. A. H., John A., Nicholls M. G., Mester J., Petroianu G., Captopril as a potential inhibitor of lung tumor growth and metastasis. Annals of the New York Academy of Sciences 2008 1138 65 72 2-s2.0-53149097024 10.1196/annals.1414.011
54. Walsh D. A., Hu D. E., Wharton J., Catravas J. D., Blake D. R., Fan T. P. D., Sequential development of angiotensin receptors and angiotensin I converting enzyme during angiogenesis in the rat subcutaneous sponge granuloma. British Journal of Pharmacology 1997 120 7 1302 1311 2-s2.0-0030997520 10.1038/sj.bjp.0701062 (Pubitemid 27149681)
55. Efferth T., Marschall M., Wang X., Huong S. M., Hauber I., Olbrich A., Kronschnabl M., Stamminger T., Huang E. S., Antiviral activity of artesunate towards wild-type, recombinant, and ganciclovir-resistant human cytomegaloviruses. Journal of Molecular Medicine 2002 80 4 233 242 2-s2.0-0036238927 10.1007/s00109-001-0300-8 (Pubitemid 34439295)
56. Bachmeier B., Fichtner I., Killian P. H., Kronski E., Pfeffer U., Efferth T., Development of resistance towards artesunate in MDA-MB-231 human breast cancer cells. PLoS ONE 2011 6 5 2-s2.0-79957572444 10.1371/journal.pone.0020550 e20550
57. Chen H. H., Zhou H. J., Wu G. D., Lou X. E., Inhibitory effects of artesunate on angiogenesis and on expressions of vascular endothelial growth factor and VEGF receptor KDR/flk-1. Pharmacology 2004 71 1 1 9 2-s2.0-1642619557 10.1159/000076256 (Pubitemid 38410706)
58. Huan-Huan C., Li-Li Y., Shang-Bin L., Artesunate reduces chicken chorioallantoic membrane neovascularisation and exhibits antiangiogenic and apoptotic activity on human microvascular dermal endothelial cell. Cancer Letters 2004 211 2 163 173 2-s2.0-3042658495 10.1016/j.canlet.2004.03.014 (Pubitemid 38824630)
59. Kowalski J., Herman Z. S., Captopril augments antitumor activity of cyclophosphamide in mice. Polish Journal of Pharmacology 1996 48 3 281 285 2-s2.0-9544258237 (Pubitemid 26294785)
60. Merchan J. R., Chan B., Kale S., Schnipper L. E., Sukhatme V. P., In vitro and in vivo induction of antiangiogenic activity by plasminogen activators and captopril. Journal of the National Cancer Institute 2003 95 5 388 399 2-s2.0-0037420209 (Pubitemid 36395259)
61. de Groot-Besseling R. R. J., Ruers T. J. M., Van Kraats A. A., Poelen G. J. M., Ruiter D. J., de Waal R. M. W., Westphal J. R., Anti-tumor activity of a combination of plasminogen activator and captopril in a human melanoma xenograft model. International Journal of Cancer 2004 112 2 329 334 2-s2.0-4544314006 10.1002/ijc.20400 (Pubitemid 39244374)
62. Prontera C., Mariani B., Rossi C., Poggi A., Rotilio D., Inhibition of gelatinase A, (MMP-2) by batimastat and captopril reduces tumor growth and lung metastases in mice bearing Lewis lung carcinoma. International Journal of Cancer 1999 81 5 761 766 (Pubitemid 29214387)